Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder Cancer
Public ClinicalTrials.gov record NCT03125460. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Clinical Evaluation of Xpert Bladder Cancer Monitor for Monitoring the Recurrence of Bladder Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this study is to establish the performance characteristics of an assay that detects the recurrence of bladder cancer in patients previously diagnosed with bladder cancer. The study is conducted at locations within and outside of the United States. Testing is performed on urine specimens provided by eligible enrolled patients. Results from this study will not be used for patient management decisions.
Study identification
- NCT ID
- NCT03125460
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 424 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years to 100 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2016
- Primary completion
- Jan 31, 2019
- Completion
- Apr 30, 2019
- Last update posted
- Feb 6, 2020
2016 – 2019
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| PAVA | Palo Alto | California | 94304 | — |
| The Urology Center of Colorado, P.C. | Denver | Colorado | 80211 | — |
| Urology Associates, P.C. | Englewood | Colorado | 80113 | — |
| North Idaho Urology | Coeur d'Alene | Idaho | 83814 | — |
| Idaho Urologic Institute | Meridian | Idaho | 83642 | — |
| UroPartners | Melrose Park | Illinois | 60160 | — |
| Five Valleys Urology | Missoula | Montana | 59808 | — |
| Weill Cornell Medicine | New York | New York | 10065-4896 | — |
| Stephenson Cancer Center | Oklahoma City | Oklahoma | 73104 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| Virginia Urology | Richmond | Virginia | 23235 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03125460, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 6, 2020 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03125460 live on ClinicalTrials.gov.